Donoghue Forlines’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,283
Closed -$2.29M 103
2025
Q1
$2.29M Buy
+17,283
New +$2.2M 0.73% 37
2024
Q4
Sell
-10,938
Closed -$1.25M 101
2024
Q3
$1.25M Buy
+10,938
New +$1.2M 0.36% 96
2023
Q1
Sell
-9,177
Closed -$1.01M 216
2022
Q4
$1.01M Buy
9,177
+4,630
+102% +$479K 0.36% 87
2022
Q3
$440K Sell
4,547
-3,237
-42% -$345K 0.16% 113
2022
Q2
$846K Sell
7,784
-7,072
-48% -$803K 0.22% 112
2022
Q1
$1.76M Sell
14,856
-3,379
-19% -$419K 0.38% 58
2021
Q4
$2.57M Buy
18,235
+9,357
+105% +$1.2M 0.43% 40
2021
Q3
$1.05M Buy
+8,878
New +$1.09M 0.2% 121

Other funds holding ABT

Donoghue Forlines's ABT Position: Q2 2025 in Review

Donoghue Forlines sold out of Abbott (ABT) in Q2 2025, closing a stake of 17,283 shares — an estimated $2.29M sold.

Donoghue Forlines first reported a position in ABT in Q3 2021 and held it in 8 quarters. The position peaked at $2.57M in Q4 2021. 3,184 funds tracked by Wall St. Rank hold ABT as of Q2 2025.

  • Donoghue Forlines reported no remaining Abbott position as of Q2 2025 after selling out during the quarter.
  • Donoghue Forlines sold 17,283 Abbott shares in Q2 2025, an estimated $2.29M.
  • Donoghue Forlines first reported a position in Abbott in Q3 2021 and held it in 8 quarters.
  • Donoghue Forlines's Abbott position peaked at $2.57M in Q4 2021.
  • 3,184 funds tracked by Wall St. Rank held Abbott as of Q2 2025.

Based on Donoghue Forlines's 13F filing for Q2 2025, filed 8 Aug 2025.